Stella-Jones (OTCMKTS:STLJF) Hits New 1-Year Low – Time to Sell?

Stella-Jones Inc. (OTCMKTS:STLJFGet Free Report)’s share price hit a new 52-week low during trading on Monday . The stock traded as low as $50.64 and last traded at $50.64, with a volume of 461 shares traded. The stock had previously closed at $51.61.

Analyst Upgrades and Downgrades

STLJF has been the topic of a number of research analyst reports. Desjardins reiterated a “buy” rating on shares of Stella-Jones in a report on Thursday, May 7th. Canadian Imperial Bank of Commerce reissued a “neutral” rating on shares of Stella-Jones in a research note on Thursday, July 9th. Finally, Royal Bank Of Canada restated a “sector perform” rating on shares of Stella-Jones in a research report on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

View Our Latest Research Report on STLJF

Stella-Jones Price Performance

The company has a market capitalization of $2.76 billion and a PE ratio of 34.37. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.11 and a current ratio of 4.96. The stock has a 50 day moving average price of $55.19 and a two-hundred day moving average price of $60.40.

Stella-Jones Company Profile

(Get Free Report)

Stella-Jones Inc is a North American producer and distributor of pressure-treated wood products used in infrastructure, utility and residential applications. The company’s core offerings include treated railroad ties, utility poles, crossarms, landscape timbers and posts designed to withstand environmental stresses and extend service life. These products support a range of end markets from railways and power transmission to fencing and outdoor construction.

Founded in 1970 and headquartered in Montreal, Canada, Stella-Jones has grown through both organic expansion and targeted acquisitions to establish a network of manufacturing and treatment facilities across Canada and the United States.

Further Reading

Receive News & Ratings for Stella-Jones Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stella-Jones and related companies with MarketBeat.com's FREE daily email newsletter.